切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - IRAK - ETA Receptors - Urokinases - 5-HT7 Receptors

12件产品中的 1-10

页面
每页
清除全部
  1. IRL-2500
    B6872 IRL-2500
    Target: ETA Receptors|ETB Receptors
    Summary: 内皮素受体拮抗剂
  2. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. Ambrisentan
    B2075 Ambrisentan
    中文名: 安贝生坦
    Target: ETA Receptors
    Summary: ETA受体拮抗剂
      ≥18.92 mg/mL
      insoluble in H2O
  6. 4-Chlorophenylguanidine hydrochloride
    A4445 4-Chlorophenylguanidine hydrochloride
    Target: Urokinases
    Summary: 尿激酶(urokinase)抑制剂
      Soluble to 100 mM in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4抑制剂
      ≥19.75 mg/mL
      insoluble in H2O
  9. IRAK inhibitor 6
    A3504 IRAK inhibitor 6
    Target: IRAK
    Summary: IRAK-4抑制剂
      ≥9.9 mg/mL
      insoluble in H2O
  10. IRAK inhibitor 4
    A3503 IRAK inhibitor 4
    Target: IRAK
    Summary: IRAK抑制剂
      Soluble in DMSO

12件产品中的 1-10

页面
每页